Table 1 Patient characteristics by COVID-19 status
Characteristics | All patients | COVID-19 | non-COVID-19 | p |
|---|---|---|---|---|
N (%) | 254 (100) | 64 (25.1) | 190 (74.9) | |
Male sex – n (%) | 172 (67.7) | 45 (70.3) | 127 (66.8) | 0.72 |
Age - years – median (IQR) | 63.3 (53.5–71.8) | 59.9 (49.3–65.1) | 65.5 (57.4–73.2) | < 0.001 |
SAPS II – median (IQR) | 45.0 (35.0-58.8) | 43.5 (34.3–56.5) | 46.0 (35.0-59.8) | 0.30 |
Mechanical ventilation DUR – median (IQR) | 0.72 (0–1) | 0.89 (0.63-1) | 0.56 (0-0.96) | < 0.001 |
Central venous catheter DUR – median (IQR) | 0.8 (0–1) | 0.90 (0.68-1) | 0.75 (0–1) | 0.044 |
Urinary catheter DUR – median (IQR) | 1 (0.95-1) | 1 (0.97-1) | 1 (0.88-1) | 0.52 |
Antibiotic treatment - n (%) | 187 (75.7) | 52 (82.5) | 135 (73.3) | 0.14 |
Days of antibiotic treatment - median (IQR) | 5 (1–12) | 9 (4–20) | 5 (0–10) | 0.001 |
ICU length of stay in days - median (IQR) | 6 (5–11) | 11 (6-22.3) | 5 (4–8) | < 0.001 |